Cargando…

N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21(cip1/waf1)/CDK2-Cyclin E1 axis-mediated cell cycle transition

Multiple myeloma (MM) is the second most common hematological malignancy. N6-methyladenosine (m(6)A) is the most abundant RNA modification. YTH domain-containing family protein 2 (YTHDF2) recognizes m(6)A-cotaining RNAs and accelerates degradation to regulate cancer progression. However, the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Rui, Miao, Jiyu, Jia, Yachun, Kong, Guangyao, Hong, Fei, Li, Fangmei, Zhai, Meng, Zhang, Ru, Liu, Jiaxi, Xu, Xuezhu, Wang, Ting, Liu, Hui, Hu, Jinsong, Yang, Yun, He, Aili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181929/ https://www.ncbi.nlm.nih.gov/pubmed/37012388 http://dx.doi.org/10.1038/s41388-023-02675-w

Ejemplares similares

Reciprocal role of cyclins and cyclin kinase inhibitor p21(WAF1/CIP1 )on lymphocyte proliferation, allo-immune activation and inflammation
por: Khanna, Ashwani K
Publicado: (2005)

N(6)-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m(6)A/cyclin D1 in asthma
por: Wang, Juan, et al.
Publicado: (2023)

The cyclin dependent kinase inhibitor p21(Cip1/Waf1) is a therapeutic target in high-risk neuroblastoma
por: Sorteberg, Agnes Luise, et al.
Publicado: (2022)

Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019)

Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21(waf1/cip1 )among human bronchogenic carcinomas
por: Harr, Michael W, et al.
Publicado: (2005)

Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
por: Shi, Y., et al.
Publicado: (1996)

The Role of the Cyclin Dependent Kinase Inhibitor p21(cip1/waf1) in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
por: Al Bitar, Samar, et al.
Publicado: (2019)

A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells
por: Gong, Y, et al.
Publicado: (2002)

The Role of Cell Cycle Regulators in Cell Survival—Dual Functions of Cyclin-Dependent Kinase 20 and p21(Cip1/Waf1)
por: Lai, Lo, et al.
Publicado: (2020)

Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
por: Koopmann, J., et al.
Publicado: (1995)

Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996)

Regenerative Response in Ischemic Brain Restricted by p21(cip1/waf1)
por: Qiu, Jianhua, et al.
Publicado: (2004)

p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin
por: Molnar, Zoltan, et al.
Publicado: (2014)

By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer
por: Zhang, Qing, et al.
Publicado: (2015)

N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
por: Chen, Lin, et al.
Publicado: (2023)

TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1)
por: Liu, Yuhui, et al.
Publicado: (2013)

Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival
por: Aaltomaa, S, et al.
Publicado: (1999)

Deficiency of the Cyclin Kinase Inhibitor p21(WAF-1/CIP-1) Promotes Apoptosis of Activated/Memory T Cells and Inhibits Spontaneous Systemic Autoimmunity
por: Lawson, Brian R., et al.
Publicado: (2004)

Cell Cycle‐dependent Modulation of Promoter Activities of RB and WAF1/Cip1 Genes
por: Matsumoto, Takuji, et al.
Publicado: (1998)

TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
por: Pisonero-Vaquero, Sandra, et al.
Publicado: (2020)

Novel cis-trans interactions are involved in post-transcriptional regulation of cyclin-dependent kinase inhibitor p21(WAF1/CIP1 )mRNA
por: Zhang, Liyue, et al.
Publicado: (2010)

p21(WAF1/CIP1) RNA Expression in Highly HIV-1 Exposed, Uninfected Individuals
por: Herbeck, Joshua, et al.
Publicado: (2015)

Ythdf is a N6‐methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila
por: Worpenberg, Lina, et al.
Publicado: (2021)

WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer.
por: Wan, M., et al.
Publicado: (1996)

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma.
por: Ogawa, M., et al.
Publicado: (1997)

Relationship between Expression of p21(WAF1/CIP1) and Radio resistance in Human Gliomas
por: Kokunai, Takashi, et al.
Publicado: (1999)

p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2019)

Accelerated Aging in Cyclophilin B–Deficient Mice Downstream of p21‐Cip1/Waf1
por: Zhang, Ying, et al.
Publicado: (2022)

Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells
por: Liu, X M, et al.
Publicado: (2003)

Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner
por: Hu, Huanrong, et al.
Publicado: (2015)

EBV-positive Hodgkin lymphoma is associated with suppression of p21(cip1/waf1 )and a worse prognosis
por: Liu, Ting-Yun, et al.
Publicado: (2010)

Epstein-Barr Virus Nuclear Antigen 3A Promotes Cellular Proliferation by Repression of the Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1
por: Tursiella, Melissa L., et al.
Publicado: (2014)

Differential targeting of the cyclin-dependent kinase inhibitor, p21(CIP1/WAF1), by chelators with anti-proliferative activity in a range of tumor cell-types
por: Moussa, Rayan S., et al.
Publicado: (2015)

Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E
por: Wang, Ying, et al.
Publicado: (2014)

H19 recruited N(6)-methyladenosine (m(6)A) reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer
por: Bai, Rumeng, et al.
Publicado: (2023)

The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review).
por: Pérez-Sayáns, Mario, et al.
Publicado: (2013)

N6‐methyladenosine reader YTHDF3 regulates melanoma metastasis via its ‘executor'LOXL3
por: Shi, Hao‐ze, et al.
Publicado: (2022)

Urinary Bladder Lesions after the Chernobyl Accident: Immunohistochemical Assessment of p53, Proliferating Cell Nuclear Antigen, Cyclin D1 and p21(WAF1/Cip1)
por: Romanenko, Alina, et al.
Publicado: (1999)

Function of p21 (Cip1/Waf1/CDKN1A) in Migration and Invasion of Cancer and Trophoblastic Cells
por: Kreis, Nina-Naomi, et al.
Publicado: (2019)

The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
por: Kreis, Nina-Naomi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3dtmkg7acdvrm34jkoatkvohqk